최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한방비만학회지 = Journal of Korean Medicine for Obesity Research, v.16 no.2, 2016년, pp.124 - 132
한경선 (동국대학교 한의과대학 한방재활의학과학교실) , 이명종 (동국대학교 한의과대학 한방재활의학과학교실) , 김호준 (동국대학교 한의과대학 한방재활의학과학교실)
In traditional medicine, Cannabis sativa L. has been used for variety of reasons. Old literatures delineate that Cannabis had been used as anesthetic and analgesic, or to reduce symptoms such as cough, paralysis and so on. Although Cannabis has a long history of medical use, it is illegal in many co...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
대마란 무엇인가? | 삼 또는 대마(大麻, Cannabis sativa L.)는 삼과(Cannabaceae) 대마속의 한해살이 식물로, 그 아종으로는 C. sativa subsp. | |
대마가 의학적으로 사용되는 곳으로는 무엇이 있나? | 그 밖에도 대마는 부위에 따라 과거에는 다양하게 사용 되어 왔는데, 삼잎인 대마초(大麻草) 혹은 마엽(麻葉)은 회충을 죽이는 작용이 있다고 하며, 마엽을 삶은 물로 머리를 감으면 머리가 길게 자라고 윤택해진다고 하였다5). 또한 천식이나 오래된 기침(氣喘), 회충(蛔蟲), 진통작용(止痛), 마취(痲醉), 이뇨제(利尿)로 사용되었다4,5). 대마의 뿌리는 마근(麻根)으로 난산(難産)과 태반이 나오지 않는 것(衣不出)을 치료하였고, 어혈을 풀고 석림(石淋)이 나오게 한다고 하였으며 복용 방법으로는 달여서 물을 마신다고 하였다5). | |
대마는 어떻게 분류되는가? | 삼 또는 대마(大麻, Cannabis sativa L.)는 삼과(Cannabaceae) 대마속의 한해살이 식물로, 그 아종으로는 C. sativa subsp. sativa, C. sativa subsp. indica, C. sativa subsp. ruderalis 등 총 3가지로 분류된다1). 과거 법적인 규제가 적용되지 않았던 시기에는 약 12,000년 동안 중앙아시아를 중심으로 열대지방과 온대지방에 걸쳐 널리 재배되었다고 알려져 있다2). |
Hillig KW. Genetic evidence for speciation in Cannabis (Cannabaceae). Genet Resour Crop Evol. 2005 ; 52(2) : 161-80.
Pain S. Cannabis: a potted history. Nature. 2015 ; 525(7570) : S10-1.
Committee of Korean Medicine Textbook Compilation. Galenic pharmacology. Seoul : Younglimsa. 2006 : 291-2.
Korea National Arboretum [Internet]. Pocheon: Korea National Arboretum; 2014 [cited 2016 Nov 4]. Available from: www.nature.go.kr.
Heo J. Principles and practice of eastern medicine; donguibogam. Seoul : Donguibogam Publishing Company. 1994.
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Pland Sci. 2016 ; 7 : 19.
Todd AR. Chemistry of the hemp drugs. Nature. 1940 ; 146 : 829-30.
Adams R, Loewe S, Jelinek C, Wolff H. Tetrahydrocannabinol homologs with marihuana activity. J Am Chem Soc. 1941 ; 63(7) : 1971-3.
Pertwee RG. Cannabinoid pharmacology: the first 66 years. Br J Pharmacol. 2006 ; 147(S1) : 163-71.
Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of cannabinoid receptor in rat rain. Mol Pharmacol. 1988 ; 34(5) : 605-13.
Devane WA, Hanus L, Breuner A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 1992 ; 258(5090) : 1946-9.
Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics. 2015 ; 12(4) : 692-8.
Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, et al. Comparison of the Paharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptor. Mol Pharmacol. 1995 ; 48(3) : 443-50.
Choe S, Yang W, Park Y, Choi H, Chung H. Classification of Cannabis sativa L. by the contents of cannabinoids and the characteristics of stable isotope. Seoul : The Pharmaceutical Society of Korea. 2011 : 264.
Burstein S. Cannabidiol (CBD) and its analogs: a review of their effects on inflammation. Bioorgan Med Chem. 2015 ; 23(7) : 1377-85.
Russo EB, Burnett A, Hall B, Parker KK. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res. 2005 ; 30(8): 1037-43.
Siger A, Nogala-Kalucka M, Lampart-Szczapa E. The content and antioxidant activity of phenolic compounds in cold-pressed plant oils. J Food Lipids. 2008 ; 15(2) : 137-49.
Werz O, Seegers J, Schaible AM, Weinigel C, Barz D, Koeberle A, et al. Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin-E2 synthase-1 and 5-lipoxygenase. Pharmanutr. 2014 ; 2(3) : 53-60.
Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpeenoids for chemotaxonomic and drug stardardization purposes, Phytochemistry. 2010 ; 71(17) : 2058-73.
Philipsen N, Butler RD. Medical marijuana: a primer on ehtics, evidence, and politics. J Nurse Pract. 2014 ; 10(9) : 633-40.
Weiss SR. The state of the science on the therapeutic potential of marijuana and Cannabinoids [Internet]. Bethesda, MD: National Institute of Drug Abuse; 2016 [cited 2016 Nov 8]. Avilable from: https://www.judiciary.senate.gov/imo/media/doc/07-13-16%20Weiss%20Testimony.pdf.
Walsh Z, Callaway R, Belle-Isle L, Capler R, Kay R, Lucas P, et al. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int J Drug Policy. 2013 ; 24(6) : 511-6.
Reinarman C, Nunberg H, Lanthier F, Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoact Drugs. 2011 ; 43(2) : 128-35.
Amar MB. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol. 2006 ; 105(1) : 1-25.
van Amsterdam J, Brunt T, van den Brink W. The adverse health effects of synthetic cannabionoids with emphasis on psychosis-like effects. J Psychopharmacol. 2015 ; 29(3) : 254-63.
Crean RD, Crane NA, Mason BJ. An evidence-based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med. 2011 ; 5(10) : 1-8.
Tuyp BJ. The adverse health effects of persistent cannabis use: Review & recommendations for change. UBC Med J. 2013 : 5(1) ; 24-9.
Hall W. What has research over the past two decades revealed about the adverse health effects of recreational cannabis use? Addiction. 2014 ; 110(1) : 19-35.
Lichtman A, Martin B. Cannabinoid tolerance and dependence. Handb Exp Pharmacol. 2005 ; 168 : 691-717.
Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2012 ; 17(6) : 642-9.
Budney A, Hughes J. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006 ; 19(3) : 233-8.
Rubino T, Parolaro D. The impact of exposure to cannabinoids in adolescence: insights from animal models. Biol Psychiatry. 2016 ; 79(7) : 578-85.
Korea Ministry of Government Legislation [Internet]. Sejong: Korea Ministry of Government Legislation; [cited 2016 Nov 8]. Available from: http://www.law.go.kr/lsInfoP.do?lsiSeq180797&ancYd20160203&efYd20160203&ancNo14019#0000.
Choi S. Policy of reaction regarding Cannabis. Korean Assoc Policy Studies Autumn Meet. 2014 ; 29 : 45.
Lee CK. The constituents of Korean Cannabis. J Pharm Soc Korea. 1973 ; 17 : 21-6.
Moon YH, Lee BH, Jeong BC, Kim YU, Kim GY. Breeding history of non-drug type hemp variety "Cheungsam" and it's characteristics. Korean J Intl Agri. 2002 ; 14(2) : 119-26.
Kennedy B. How Israel has become global leader in cannabis research [Internet]. Denver, CO: The Cannabist; [cited 2016 Nov 8]. Available from: http://www.thecannabist.co/2016/09/28/israel-cannabis-research/63987/.
Hoffmann DE, Weber E. Medical marijuana and the law. N Engl J Med. 2010 ; 362(16) : 1453-57.
Bifulco M, Pisanti S. Medical use of cannabis in europe. EMBO Rep. 2015 ; 16(2) : 130-2.
Spithoff S, Emerson B, Spithoff A. Cannabis legalization: adhering to public health best practice. CMAJ. 2015 ; 187(16) : 1211-6.
De Petroclellis L, Ligresti A, Moriello AS, Allara M, Bisogno T, Petrosino S. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011 ; 163(7) : 1479-94.
Wagner H, Ultrich-Merzenich G. Syndergy research: appreoaching a new generation of phytopharmaceuticals. Phytomedicine. 2009 ; 16(2) : 97-110.
Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effect. Br J Pharmacol. 2011 ; 163(7) : 1344-64.
Mehra R, Moore BA, Crothers K, Tetrault J, Fiellin DA. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med. 2006 ; 166(13) : 1359-67.
Gieringer DH. Cannabis "Vaporization" a promising strategy for smoke harm reduction. J Cannabis Ther. 2001 ; 1(3-4) : 153-70.
Perez J. Combined cannabinoid therapy via an oromucosal spray. Drugs Today. 2006 ; 42(8) : 495-503.
Politi M, Peschel W, Wilson N, Zloh M, Prieto JM, Heinrich M. Direct NMR analysis of cannabis water extracts and tinctures and semi-quantitative data on ${\Delta}$ 9-THC and ${\Delta}$ 9-THC-acid. Phytochemistry. 2008 ; 69(2) : 562-70.
Charavarty I, Sengupta D, Bhattacharyya P, Ghosh JJ. Effect of treatment with cannabis extract on the water and glycogen contents of the uterus in normal and estradiol-treated prepubertal rats. Toxicol Appl pharmacol. 1975 ; 34(3) : 513-6.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.